Raia Drogasil S.A.
RADLY
$3.56
-$0.26-6.81%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.93% | -10.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.93% | -10.05% | |||
| Cost of Revenue | 3.89% | -13.45% | |||
| Gross Profit | 10.25% | -1.92% | |||
| SG&A Expenses | 5.19% | 0.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -97.00% | -- | |||
| Total Operating Expenses | 2.32% | -8.27% | |||
| Operating Income | 86.06% | -37.14% | |||
| Income Before Tax | 323.29% | -56.92% | |||
| Income Tax Expenses | 663.96% | -266.87% | |||
| Earnings from Continuing Operations | 186.06% | -47.79% | |||
| Earnings from Discontinued Operations | -28.32% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 170.30% | -46.30% | |||
| EBIT | 86.06% | -37.14% | |||
| EBITDA | 60.01% | -32.87% | |||
| EPS Basic | 170.11% | -49.59% | |||
| Normalized Basic EPS | 300.00% | -67.02% | |||
| EPS Diluted | 173.18% | -50.82% | |||
| Normalized Diluted EPS | 305.49% | -67.96% | |||
| Average Basic Shares Outstanding | 0.01% | 6.40% | |||
| Average Diluted Shares Outstanding | -1.02% | 9.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 186.88% | -1.00% | |||